Home
>
National Drug Code (NDC)
>
Ondansetron
Ondansetron - 10019-905-01 - (Ondansetron Hydrochloride)
Drug Information of Ondansetron
| Product NDC: | 10019-905 |
| Proprietary Name: | Ondansetron |
| Non Proprietary Name: | Ondansetron Hydrochloride |
| Active Ingredient(s): | 2 mg/mL & nbsp; Ondansetron Hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ondansetron
| Product NDC: | 10019-905 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077541 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101119 |
Package Information of Ondansetron
| Package NDC: | 10019-905-01 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-905-01) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-905-17) |
NDC Information of Ondansetron
| NDC Code | 10019-905-01 |
| Proprietary Name | Ondansetron |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-905-01) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-905-17) |
| Product NDC | 10019-905 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ondansetron Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20101119 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | ONDANSETRON HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
